Reanalysis of Cost-Effectiveness of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer in Japan Using a Japanese Claim Data Set
May 1, 2014, 00:00
10.1016/j.jval.2014.03.498
https://www.valueinhealthjournal.com/article/S1098-3015(14)00549-X/fulltext
Title :
Reanalysis of Cost-Effectiveness of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer in Japan Using a Japanese Claim Data Set
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00549-X&doi=10.1016/j.jval.2014.03.498
First page :
A85
Section Title :
Cancer
Open access? :
No
Section Order :
1544